(Q43919678)

28 November 2017

title

Studies of the binding of a series of platinum(IV) complexes to plasma proteins (English)

1 reference

28 November 2017

1 reference

2

1 reference

28 November 2017

3

Trevor W Hambley

0 references

author name string

Rachael C Dolman

series ordinal

1

1 reference

28 November 2017

Trevor W Hambley

series ordinal

3

1 reference

28 November 2017

publication date

1 February 2002

1 reference

Journal of Inorganic Biochemistry

28 November 2017

published in

1 reference

28 November 2017

volume

88

1 reference

28 November 2017

issue

3-4

1 reference

28 November 2017

page(s)

260-267

1 reference

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Current status of platinum-based antitumor drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Why does Cisplatin reach Guanine-n7 with competing s-donor ligands available in the cell?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Drugs five years later. Cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Resistance to platinum compounds: mechanisms and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Fundamental studies with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Reactions of cisplatin hydrolytes with methionine, cysteine, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

DNA interactions of antitumor platinum(IV) complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Glutathione-mediated activation of anticancer platinum(IV) complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Interaction of the antitumor agents cis,cis,trans-PtIV(NH3)2Cl2(OH)2 and cis,cis,trans-PtIV[(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Cisplatin binding sites on human albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Pharmacokinetic-dynamic relationship of cisplatin in vitro: simulation of an i.v. bolus and 3 h and 20 h infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Ring-Opened Adducts of the Anticancer Drug Carboplatin with Sulfur Amino Acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Three-dimensional structure of human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Interaction of human serum albumin with anticancer agents in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Atomic structure and chemistry of human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Surprising Reactions of Iodo Pt(IV) and Pt(II) Complexes with Human Albumin: Detection of Cys34 Sulfenic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Effect of cis-, trans-diamminedichloroplatinum(II) and DBP on human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Modifying the properties of platinum (IV) complexes in order to increase biological effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Preparation, characterization, and antitumor activity of new ethylenediamine platinum(IV) complexes containing mixed carboxylate ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Reactions of Chromium(VI/V/IV) with Bis(O-ethyl-l-cysteinato-N,S)zinc(II): A Model for the Action of Carcinogenic Chromium on Zinc-Finger Proteins1

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

Studies on the human metabolism of iproplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-0134%2801%2900360-9

7 January 2021

10.1016/S0162-0134(01)00360-9

Identifiers

DOI

1 reference

28 November 2017

1 reference